医学
乳腺癌
生活质量(医疗保健)
内科学
化疗
入射(几何)
认知
癌症相关疲劳
癌症
辅助化疗
肿瘤科
物理疗法
精神科
光学
物理
护理部
作者
Nadine Tchen,Helen G. Juffs,Fiona Downie,Qilong Yi,Hanxian Hu,I. Chemerynsky,Mark Clemons,Michael Crump,Paul E. Goss,David Warr,Mary E. Tweedale,Ian F. Tannock
标识
DOI:10.1200/jco.2003.01.119
摘要
There is evidence that cognitive dysfunction, fatigue, and menopausal symptoms may occur in women receiving adjuvant chemotherapy for breast cancer. Here, we determine their incidence and severity, and interrelationships between them and quality of life.In this study, 110 women receiving adjuvant chemotherapy each nominated a female relative, friend, or neighbor (matched by age) as a control; 100 eligible matched pairs were evaluated. Patients and controls completed the following assessments: the High-Sensitivity Cognitive Screen, and the Functional Assessment of Cancer Therapy-General (FACT-G) quality of life scale with subscales for fatigue (FACT-F) and endocrine symptoms (FACT-ES). They also performed tests of attention and reaction time.Patients and controls were well matched for age and level of education. There was a higher incidence of moderate or severe cognitive impairment in the patient group (16% v 4%; P =.008). Patients experienced much more fatigue than controls (median FACT-F scores, 31 v 46; P <.0001) and more menopausal symptoms (median FACT-ES scores, 58 v 64; P <.0001). Self-reported quality of life of the patients was poorer than for controls, especially in physical and functional domains (median FACT-G scores, 77 v 93; P <.0001). There was strong correlation between fatigue, menopausal symptoms, and quality of life (P <.0001 for each pair), but none were significantly associated with the presence of cognitive dysfunction.Adjuvant chemotherapy causes cognitive dysfunction, fatigue, and menopausal symptoms in women with breast cancer. Priority should be given to the study of strategies that might reduce these toxic effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI